UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characteristics of people living with undiagnosed dementia: findings from the CFAS Wales study

BMC geriatrics, 2022-05, Vol.22 (1), p.409-12, Article 409

2022

Volltextzugriff (PDF)

Cortical depth-specific microvascular dilation underlies laminar differences in blood oxygenation level-dependent functional MRI signal

Proceedings of the National Academy of Sciences - PNAS, 2010-08, Vol.107 (34), p.15246-15251

2010

Volltextzugriff (PDF)

Intermittent pneumatic compression for treating venous leg ulcers

Cochrane database of systematic reviews, 2014-05, Vol.2014 (5), p.CD001899-CD001899

2014

Volltextzugriff (PDF)

Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID-19 Study

American journal of respiratory and critical care medicine, 2023-03, Vol.207 (6), p.693-703

2023

Volltextzugriff (PDF)

Antigen dominance hierarchies shape TCF1+ progenitor CD8 T cell phenotypes in tumors

Cell, 2021-09, Vol.184 (19), p.4996-5014.e26

2021

Volltextzugriff (PDF)

Should Elderly Non–Small-Cell Lung Cancer Patients Be Offered Elderly-Specific Trials? Results of a Pooled Analysis From the North Central Cancer Treatment Group

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9113-9119

2005

Volltextzugriff (PDF)

Phase II Study of the Farnesyl Transferase Inhibitor R115777 in Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2003-05, Vol.21 (9), p.1760-1766

2003

Volltextzugriff (PDF)

Long-Term Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non–Small Cell Lung Cancer: NCCTG N0028 (Alliance)

Journal of thoracic oncology, 2017-04, Vol.12 (4), p.697-703

2017

Volltextzugriff (PDF)

Randomized Phase II Trial of Three Schedules of Pemetrexed and Gemcitabine As Front-Line Therapy for Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2005-09, Vol.23 (25), p.5929-5937

2005

Volltextzugriff (PDF)

A prognostic model for advanced stage nonsmall cell lung cancer : Pooled analysis of north central cancer treatment group trials

Cancer, 2006-08, Vol.107 (4), p.781-792

2006

Volltextzugriff (PDF)

Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non–small-cell lung cancer

International journal of radiation oncology, biology, physics, 2006-07, Vol.65 (4), p.1106-1111

2006

Volltextzugriff (PDF)

A Front-Line Window of Opportunity Phase 2 Study of Sorafenib in Patients With Advanced Nonsmall Cell Lung Cancer: North Central Cancer Treatment Group Study N0326

Cancer, 2010-12, Vol.116 (24), p.5686-5693

2010

Volltextzugriff (PDF)

Comparison of Continuous versus Categorical Tumor Measurement-Based Metrics to Predict Overall Survival in Cancer Treatment Trials

Clinical cancer research, 2011-10, Vol.17 (20), p.6592-6599

2011

Volltextzugriff (PDF)

Impact of disease progression date determination on progression‐free survival estimates in advanced lung cancer

Cancer, 2012-11, Vol.118 (21), p.5358-5365

2012

Volltextzugriff (PDF)

Perceptual and conceptual processing of visual objects across the adult lifespan

Scientific reports, 2019-09, Vol.9 (1), p.13771-13, Article 13771

2019

Volltextzugriff (PDF)

Results of a Phase II Study of High-Dose Thoracic Radiation Therapy With Concurrent Cisplatin and Etoposide in Limited-Stage Small-Cell Lung Cancer (NCCTG 95-20-53)

Journal of clinical oncology, 2007-07, Vol.25 (21), p.3124-3129

2007

Volltextzugriff (PDF)

Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51)

Lung cancer (Amsterdam, Netherlands), 2008-05, Vol.60 (2), p.200-207

2008

Volltextzugriff (PDF)

Endpoints in Phase II Trials for Advanced Non-small Cell Lung Cancer

Journal of thoracic oncology, 2010-01, Vol.5 (1), p.3-9

2010

Volltextzugriff (PDF)

LONG-TERMS RESULTS OF A TRIAL OF CONCURRENT CHEMOTHERAPY AND ESCALATING DOSES OF RADIATION FOR UNRESECTABLE NON–SMALL CELL LUNG CANCER: NCCTG N0028 (ALLIANCE)

Journal of thoracic oncology, 2017-01, Vol.12 (4), p.697-703

2017

Volltextzugriff (PDF)

A phase II trial of a combination of pemetrexed and gemcitabine in patients with metastatic breast cancer: an NCCTG study

Annals of oncology, 2006-02, Vol.17 (2), p.226-231

2006

Volltextzugriff (PDF)

A Front-Line “Window of Opportunity” Phase II Study of Sorafenib in Patients with Advanced Non-small Cell Lung Cancer (NSCLC)– A North Central Cancer Treatment Group Study N03261

Cancer, 2010-12, Vol.116 (24), p.5686-5693

2010

Volltextzugriff (PDF)

A front‐line window of opportunity phase 2 study of sorafenib in patients with advanced nonsmall cell lung cancer

Cancer, 2010-12, Vol.116 (24), p.5686-5693

2010

Volltextzugriff (PDF)

A prognostic model for advanced stage nonsmall cell lung cancer

Cancer, 2006-08, Vol.107 (4), p.781-792

2006

Volltextzugriff (PDF)

CHANGES IN EXTRACELLULAR CONCENTRATIONS OF SOME CYTOKINES, CHEMOKINES, AND NEUROTROPHIC FACTORS AFTER INSERTION OF INTRACEREBRAL MICRODIALYSIS CATHETERS IN NEUROSURGICAL PATIENTS. Commentary

Neurosurgery, 2008, Vol.62 (1), p.151-158

2008

Volltextzugriff (PDF)

Endpoints in Phase II trials for advanced non-small cell lung cancer 1

Journal of thoracic oncology, 2010-01, Vol.5 (1), p.3-9

2010

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(26)
Berichte
(1)

Sprache

Englisch
(27)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(20)
Humans
(19)
Life Sciences & Biomedicine
(18)
Aged
(14)
Female
(14)
Oncology
(14)
Biological And Medical Sciences
(12)
Male
(12)
Medical Sciences
(12)
Middle Aged
(11)
Aged, 80 And Over
(9)
Lung Neoplasms - Pathology
(8)
Tumors
(8)
Adult
(7)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(7)
Lung Neoplasms - Drug Therapy
(7)
Pneumology
(7)
Prognosis
(7)
Tumors Of The Respiratory System And Mediastinum
(7)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Characteristics of people living with undiagnosed dementia: findings from the CFAS Wales study

Cortical depth-specific microvascular dilation underlies laminar differences in blood oxygenation level-dependent functional MRI signal

Intermittent pneumatic compression for treating venous leg ulcers

Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID-19 Study

Antigen dominance hierarchies shape TCF1+ progenitor CD8 T cell phenotypes in tumors

Should Elderly Non–Small-Cell Lung Cancer Patients Be Offered Elderly-Specific Trials? Results of a Pooled Analysis From the North Central Cancer Treatment Group

Phase II Study of the Farnesyl Transferase Inhibitor R115777 in Patients With Advanced Non–Small-Cell Lung Cancer

Long-Term Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non–Small Cell Lung Cancer: NCCTG N0028 (Alliance)

Randomized Phase II Trial of Three Schedules of Pemetrexed and Gemcitabine As Front-Line Therapy for Advanced Non–Small-Cell Lung Cancer

A prognostic model for advanced stage nonsmall cell lung cancer : Pooled analysis of north central cancer treatment group trials

Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non–small-cell lung cancer

A Front-Line Window of Opportunity Phase 2 Study of Sorafenib in Patients With Advanced Nonsmall Cell Lung Cancer: North Central Cancer Treatment Group Study N0326

Comparison of Continuous versus Categorical Tumor Measurement-Based Metrics to Predict Overall Survival in Cancer Treatment Trials

Impact of disease progression date determination on progression‐free survival estimates in advanced lung cancer

Perceptual and conceptual processing of visual objects across the adult lifespan

Results of a Phase II Study of High-Dose Thoracic Radiation Therapy With Concurrent Cisplatin and Etoposide in Limited-Stage Small-Cell Lung Cancer (NCCTG 95-20-53)

Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51)

Endpoints in Phase II Trials for Advanced Non-small Cell Lung Cancer

LONG-TERMS RESULTS OF A TRIAL OF CONCURRENT CHEMOTHERAPY AND ESCALATING DOSES OF RADIATION FOR UNRESECTABLE NON–SMALL CELL LUNG CANCER: NCCTG N0028 (ALLIANCE)

A phase II trial of a combination of pemetrexed and gemcitabine in patients with metastatic breast cancer: an NCCTG study

A Front-Line “Window of Opportunity” Phase II Study of Sorafenib in Patients with Advanced Non-small Cell Lung Cancer (NSCLC)– A North Central Cancer Treatment Group Study N03261

A front‐line window of opportunity phase 2 study of sorafenib in patients with advanced nonsmall cell lung cancer

A prognostic model for advanced stage nonsmall cell lung cancer

CHANGES IN EXTRACELLULAR CONCENTRATIONS OF SOME CYTOKINES, CHEMOKINES, AND NEUROTROPHIC FACTORS AFTER INSERTION OF INTRACEREBRAL MICRODIALYSIS CATHETERS IN NEUROSURGICAL PATIENTS. Commentary

Endpoints in Phase II trials for advanced non-small cell lung cancer 1

Suchergebnisse filtern